Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction
The value of thrombolytic therapy for patients with acute myocardial infarction has been firmly established. To identify the thrombolytic approach that most effectively produces sustained patency of the infarct-related artery and improves survival, the Global Utilization of Streptokinase and Tissue...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1995-05, Vol.332 (21), p.1418-1424 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The value of thrombolytic therapy for patients with acute myocardial infarction has been firmly established. To identify the thrombolytic approach that most effectively produces sustained patency of the infarct-related artery and improves survival, the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) investigators compared four different regimens: accelerated tissue plasminogen activator (t-PA), streptokinase with intravenous heparin, streptokinase with subcutaneous heparin, and a combination of t-PA and streptokinase.
1
(“Accelerated” refers to the administration of t-PA over a period of 11/2 hours — with two thirds of the dose given in the first 30 minutes — rather . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM199505253322106 |